Nonstatin Therapy for Managing Residual Atherosclerotic Cardiovascular Disease Risk
hosted byAmerican College of Cardiology (ACC)Nonstatin Therapy for Managing Residual Atherosclerotic Cardiovascular Disease Risk is organized by American College of Cardiology (ACC).
Date of Release: August 1, 2022
Term of Approval/Date of Expiration: July 31, 2025
Description:
The goal of this activity is for participants to be able to determine an evidence-based treatment plan that includes ensuring the optimization of statin and non-statin therapies to decrease ASCVD risk. This activity is part of the Modern Lipid Management: The Updated Medicine Cabinet grant project.
Learner Objectives:
Upon completion of this activity, you should be able to:
• Select appropriate patients who would benefit from the novel and emerging non-statin therapies.
Additional details will be posted as soon as information is available.
